CURE 2nd External Newsletter
Contents:
- Where are we in the project? – Project update
- Interview with Prof David Roberson – “The microbiome has been shown to influence the progression of asthma and viruses can be key triggers”
- Analysis on the opportunities and limitations of the current European Regulatory Framework for Bacteriophage therapy;
- This article goes accompanied with an interview with Dr Jean-Paul Pirnay, member of CURE Ethics Advisory Board. All the interview here: https://www.youtube.com/watch?v=ub0ckFn8WZg
- Cure at the European Research and Innovation Days
- Nomination of BRFAA for the Innovation Radar Prize
